|
| [November 27, 2012] |
 |
Research and Markets: Barretts Esophagus Global Clinical Trials Review, H2, 2012
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/mhgs7n/barretts)
has announced the addition of GlobalData's new report "Barretts
Esophagus Global Clinical Trials Review, H2, 2012" to their offering.
"Barretts Esophagus Global Clinical Trials Review, H2, 2012" provides
data on the Barretts Esophagus clinical trial scenario. This report
provides elemental information and data relating to the clinical trials
on Barretts Esophagus. It includes an overview of the trial numbers and
their recruitment status as per the site of trial conduction across the
globe. The databook offers a prliminary coverage of disease clinical
trials by their phase, trial status, prominence of the sponsors and also
provides briefing pertaining to the number of trials for the key drugs
for treating Barretts Esophagus.
Scope
- Data on the number of clinical trials conducted in North America,
South and Central America, Europe, Middle-East and Africa and
Asia-pacific and top five national contributions in each, along with the
clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status,
subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed
manner
- Abridged view of the performance of the trials in terms of their
status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes /
Hospitals or Companies
For more information visit http://www.researchandmarkets.com/research/mhgs7n/barretts.
Source (News - Alert): GlobalData

[ Back To Technology News's Homepage ]
|